StockRing: 11/14/09, (NYSE:DGX), $58.64, "SUPER BUY" QUEST DIAGNOSTC (DGX) Stock on Saturday, November 14, 2009

Login    About Us    Our Blog    Our Twitter    Contact Us     11/14/09, (NYSE:DGX), $58.64, "SUPER BUY" QUEST DIAGNOSTC (DGX) Stock  DGX opened at $58.16 and it is $+0.48, (+0.83%). Today's trading range is $58.05 - 58.88. 1y target price is $63.70.  DOW     +0.72%    +73.00    10270.47           ENGLAND     +0.38%    +19.88    5296.38           JAPAN     -0.35%    -34.18    9770.31  NASDAQ     +0.88%    +18.86    2167.88           GERMANY     +0.40%    +22.87    5686.83           CHINA     +0.46%    +14.7    3187.647  S&P 500     +0.57%    +6.24    1093.48           FRANCE     -0.05%    -2.06    3806.01           INDIA     +0.92%    +152.8    16848.83  CANADA     +0.41%    +46.92    11407.68           ITALY     -1.09%    -174.00    15743.00           RUSSIA     -0.41%    -5.85    1419.49  MEXICO     +0.79%    +242.24    31002.090           SWISS     -0.07%    -4.68    6351.08           TAIWAN     -0.07%    -5.3    7665.63

Stocks Funds SYMBOL:    YouTube Our Blog 11/11/09 StockRing Urgent Advice: Buy stocks on 11/12/09 - expect gains this week !!!    Option Exp: SAMPLE ! Option Exp:    EUROs for $1 DOLLAR: 3 MONTHS       Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!! 1. Dow Jones Index - 30 Stocks on 11/12/2009:  Buy   93% or 28   Hold   7% or 2   Sell   0% or 0 stocks     2. World Markets - 72 Indexes on 11/11/2009:  Buy   63% or 44   Hold   21% or 15   Sell   16% or 11 indexes 3. Best Brands - 200 stocks on 11/12/2009:  Buy   76% or 152   Hold   17% or 33   Sell   7% or 14 stocks 4. Hot News - 200 stocks on 11/8/2009:  Buy   47% or 93   Hold   23% or 46   Sell   30% or 60 stocks 5. Big Movers - 200 stocks on  TODAY :  Buy   69% or 137   Hold   23% or 47   Sell   8% or 15 stocks 6. Top Hitters - 200 stocks on 11/11/2009:  Buy   77% or 153   Hold   15% or 31   Sell   8% or 15 stocks 7. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 9. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 10. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 11. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 12. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 13. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 14. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 15. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 16. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 17. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks                                              TOTAL RATINGS:   Buy   60% or 2493   Hold   27% or 1080   Sell   13% or 517 stocks Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings 11/14/2009  Saturday, November 14, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SUPER BUY"for QUEST DIAGNOSTC (NYSE:DGX) Stock. DGX stock opening price was $58.16 per share. Current price of NYSE:DGX Stock is $58.64 per share and it is $+0.48, (+0.83%) today and it was trading in the daily range of $58.05 - 58.88 per share. Current Bid Price for (NYSE:DGX) stock is $57.88 and the Ask Price is $59.51. In the last 52 weeks DGX stock was trading in the range of $40.00 - 58.28. 50-Day Moving Average for (NYSE:DGX) stock is $54.5078 and 200-Day Moving Average is $53.6472. On average analysts predict that One Year Target Estimated price for (NYSE:DGX) stock is $63.70. QUEST DIAGNOSTC (NYSE:DGX) Market capitalization is $10.843B. (NYSE:DGX) stock average daily volume is 1,524,860 shares per day. However, on last trading session of Nov 13, 2009 DGX stock traded 1,192,261 shares. Also The Short Ratio for (NYSE:DGX) stock is 3.60. On previous trading session DGX Stock closed at $58.16 per share. Last year QUEST DIAGNOSTC (NYSE:DGX) before taxes (EBITDA) (ttm) earned $1.606B on total revenue of $7.407B. Earnings Per Share - EPS (ttm) for DGX stock is 3.774. Also, (NYSE:DGX) Stock Price Per Earnings ratio - P/E is 15.41. Thus, (NYSE:DGX) Stock Price/Sales (ttm) ratio is 1.45 and Price/Book (mrq) ratio is 2.75. (NYSE:DGX) Stock pays a dividend of $0.40 per share which is a yield of 0.69%. So at this time (NYSE:DGX) Stock maintains Trailing Annual Dividend Rate at 0.40 . StockRing Recommendations for QUEST DIAGNOSTC (NYSE:DGX) Stock are updated daily here http://www.StockRing.com/sr/StockDetail.asp?StockName=DGX If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com. DGX Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 11/14/2009 1 Year Stock market price chart for QUEST DIAGNOSTC (NYSE:DGX) Stock on Saturday, November 14, 2009    1 Year Dow Jones Chart 1 Year S&P 500 Chart 1 Year Nasdaq Chart 1 Year Canada Chart 11/14/2009 5 days Stock market price chart for QUEST DIAGNOSTC (NYSE:DGX) Stock on Saturday, November 14, 2009    5 Days Dow Jones Chart 5 Days S&P 500 Chart 5 Days Nasdaq Chart 5 Days Canada Chart DGX Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 11/14/2009 Stock market price quote data for QUEST DIAGNOSTC (NYSE:DGX) Stock on Saturday, November 14, 2009 Last Trade: 58.64 Trade Time: Nov 13 Change: +0.48, (+0.83%) Prev Close: 58.16 Open: 58.16 Bid: 57.88 Ask: 59.51 1y Target Est: $63.70 50-Day Moving Average: 54.5078 200-Day Moving Average: 53.6472 Short Ratio: 3.60 Trailing Annual Dividend Rate: 0.40 Day's Range: 58.05 - 58.88 52wk Range: 40.00 - 58.28 Volume: 1,192,261 Avg Vol: 1,524,860 Market Cap: 10.843B P/E (ttm): 15.41 EPS (ttm): 3.774 Div & Yield: 0.40 (0.69%) Revenue (ttm): 7.407B Earnings before Tax (EBITDA) (ttm): 1.606B Price/Sales (ttm): 1.45 Price/Book (mrq): 2.75 Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!    EUROs for $1 DOLLAR: 3 MONTHS       QUEST DIAGNOSTC (NYSE: DGX) Company Infromation Quest Diagnostics Inc. 3 Giralda Farms Madison, NJ 07940 United States - Map Phone: 973-520-2700 Web Site: http://www.questdiagnostics.com QUEST DIAGNOSTC (NYSE: DGX) DETAILS QUEST DIAGNOSTC (NYSE: DGX) Index Membership: S&P 500 S&P 1500 Super Comp QUEST DIAGNOSTC (NYSE: DGX) Sector: Healthcare QUEST DIAGNOSTC (NYSE: DGX) Industry: Medical Laboratories & Research QUEST DIAGNOSTC (NYSE: DGX) Full Time Employees: 42,800 QUEST DIAGNOSTC (NYSE: DGX) BUSINESS SUMMARY Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. It provides patients and physicians the access to diagnostic laboratory services through its network of laboratories and owned patient service centers; and interpretive consultation. The company also offers commercial clinical testing services, including routine clinical testing for blood chemistries, complete blood cell counts, urinalyses, pregnancy and other prenatal tests, microbiology testing, alcohol and other substance-abuse tests, and allergy tests; cancer diagnostics, such as anatomic pathology services; and gene-based and other esoteric testing. In addition, it offers various risk assessment services for insurance companies. Further, Quest Diagnostics develops and manufactures products that enable healthcare professionals to make healthcare diagnoses, including HerpeSelect ELISA tests that detect patient antibodies to certain types of Herpes Simplex virus and are sold to academic medical centers, hospitals, and commercial laboratories; White Blood Cell Analyzer, a whole-blood test performed on finger-stick samples for providing a total white blood cell count; and InSure fecal immunochemical test for screening for colorectal cancer. Additionally, it develops and integrates clinical connectivity and data management solutions for healthcare organizations, physicians, and clinicians through its Care360 suite of products; offers the ChartMaxx electronic document management system for hospitals; and has capabilities to deploy a health information exchange system enabling healthcare providers to access and manage patient data from multiple sources at the point-of-care. Quest Diagnostics also collaborates with Google to launch Google Health that allows patients to share, save, organize, and manage their medical records and personal health information online. The company was founded in 1967 and is headquartered in Madison, New Jersey. QUEST DIAGNOSTC (NYSE: DGX) KEY EXECUTIVES, SALARIES and BONUSES Dr. Surya N. Mohapatra Ph.D., Age: 59 Chairman, Chief Exec. Officer, Pres and Chairman of Exec. Committee Salary: $ 3.06M Bonus: $ 4.51M Mr. Robert A. Hagemann , Age: 52 Chief Financial Officer and Sr. VP Salary: $ 1.04M Bonus: $ 0 Mr. Wayne R. Simmons , Age: 53 VP of Operations Salary: $ 724.00K Bonus: $ 0 Dr. Joan E. Miller Ph.D., Age: 54 Sr. VP of Pathology & Hospital Services Salary: $ 768.00K Bonus: $ 0 Mr. Michael E. Prevoznik , Age: 47 Sr. VP of Legal & Compliance and Gen. Counsel Salary: $ 774.00K Bonus: $ 0 1. Dow Jones Index - 30 Stocks on 11/12/2009:  Buy   93% or 28   Hold   7% or 2   Sell   0% or 0 stocks     2. World Markets - 72 Indexes on 11/11/2009:  Buy   63% or 44   Hold   21% or 15   Sell   16% or 11 indexes 3. Best Brands - 200 stocks on 11/12/2009:  Buy   76% or 152   Hold   17% or 33   Sell   7% or 14 stocks 4. Hot News - 200 stocks on 11/8/2009:  Buy   47% or 93   Hold   23% or 46   Sell   30% or 60 stocks 5. Big Movers - 200 stocks on  TODAY :  Buy   69% or 137   Hold   23% or 47   Sell   8% or 15 stocks 6. Top Hitters - 200 stocks on 11/11/2009:  Buy   77% or 153   Hold   15% or 31   Sell   8% or 15 stocks 7. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 9. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 10. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 11. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 12. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 13. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 14. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 15. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 16. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 17. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks                                              TOTAL RATINGS:   Buy   60% or 2493   Hold   27% or 1080   Sell   13% or 517 stocks 11/14/2009 Latest stock market news data for QUEST DIAGNOSTC (NYSE:DGX) Stock on Saturday, November 14, 2009 Quest Diagnostics Incorporated Reaffirms FY 2009 Guidance Reuters Key Development - 21 hours ago BofA Merrill Lynch, Morgan Stanley, RBS, Wells Fargo Securities to run Quest's note offering Trading Markets - Nov 13, 2009 Nov 13, 2009 (M2 EQUITYBITES via COMTEX) -- WFC -- 13 November 2009 - US company Quest Diagnostics Inc (NYSE:DGX) said on Thursday it had picked BofA Merrill Lynch, Morgan Stanley (NYSE:MS), RBS ... New Issue-Quest Diagnostics sells $750 mln of notes Reuters - Nov 12, 2009 Nov 12 (Reuters) - Quest Diagnostics (DGX.N) on Thursday sold $750 million of notes in two parts, said IFR, a Thomson Reuters service. Bank of America, Morgan Stanley, RBS, and Wells Fargo were ... Forward Calendar - U.S. corporate bond new issues Reuters - Nov 12, 2009 Nov 13 (Reuters) - The following are lists of upcoming high-grade and high-yield corporate bond offerings in the United States. The information was gathered from Thomson Reuters US new issues team ... Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes CNNMoney.com - Nov 12, 2009 MADISON, NJ, Nov. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced ... Quest Diagnostics to Offer $750M of Notes To Fund Buyback - Wall Street Journal Quest Diagnostics offering cash for senior notes - San Jose Mercury News SYS-CON Media - StreetInsider.com - RTT News Quest Diagnostics to Speak at the Lazard Capital Markets 6th Annual Healthcare Conference CNNMoney.com - Nov 12, 2009 MADISON, NJ, Nov. 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is ... Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering - Stockhouse Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering Reuters Key Development - Nov 12, 2009 Robert E. Kirby, President and Chief Executive Officer Announces Resignation Trading Markets - Nov 9, 2009 WILMINGTON, Mass., Nov 09, 2009 (BUSINESS WIRE) -- DGX -- Accellent, a leading provider of outsourced precision manufacturing and engineering services to the medical device industry, announced ... Quest Diagnostics to Offer New Colorectal Cancer Test Gerson Lehrman Group - Nov 9, 2009 Quest Diagnostics senior spokesperson Jay Wohlgemuth said that Quest plans to launch a new Laboratory Developed Test (LDT) for colorectal cancer based on Epigenomics' mSEPT9 DNA-methylation ... DMI Software helps hospitals handle RAC audit requests. ThomasNet Industrial News Room - Nov 9, 2009 CINCINNATI, Nov. 2 -- MedPlus®, the healthcare information technology subsidiary of Quest Diagnostics® Incorporated (NYSE: DGX), today announced the release of ChartMaxx® V5.5, an upgrade to its ... Quest Diagnostics offering cash for senior notes The Associated Press ... used for general corporate purposes like acquisitions, capital spending and baying back debt. In morning trading, Quest stock picked up 47 cents to $58.61. Quest Diagnostics To Offer $750 Million Of Senior Notes; Begins Cash Tender ...RTT News all 96 news articles » BEFORE THE BELL:US Stock Futures Up Ahead Of Earnings Wall Street Journal US stock futures rose on Monday as a busy week of earnings reports kicks off and as Federal Reserve Chairman Ben Bernanke hinted that ... BEFORE THE BELL:US Stock Futures Remain HigherWall Street Journal all 7 news articles » CORRECT: Quest 3Q Profit Climbs 74% On Strong Demand Wall Street Journal Quest Diagnostics Inc.'s (DGX) third-quarter earnings rose 74% amid increasing demand for medical diagnostic testing, and the results beat Wall Street's ... Quest Diagnostics Q3 EPS Tops Estimate; Boosts FY09 Profit Outlook - UpdateTrading Markets (press release) Quest Diagnostics Inc., Q3 2009 (Qtr End 09/30/09) Earnings Call TranscriptSeeking Alpha (blog) all 29 news articles » Left Behind: Quality Stocks That Missed the Rally BusinessWeek 2 player in the clinical testing market, behind Quest Diagnostics (DGX), also has a compelling valuation, according to Zeke Ashton, the founder and managing ... and more » Health Discovery Corporation Offers an Intra-Quarterly Update, Commentary on ... Reuters "Additionally, we were proud to be recently listed by the Wall Street Journal Market Watch as a "Best Performing Stock" in the Biotechnology sector. ... and more » Stock research report available on Quest Diagnostics (NYSE:DGX) from smartrend ... TMCnet ... our proprietary pattern recognition system, called an Uptrend for Quest Diagnostics (NYSE:DGX) on October 09, 2009 at $54.49. ... and more » Stock Rating Reiterations: CAT CMA CYMI DD EXPE Wall Street Journal ... Roth Capital Hold Precision Castparts PCP Credit Suisse Neutral Priceline.com PCLN Credit Suisse Outperform Quest Diagnostics DGX Credit Suisse Neutral ... Stock research report available on Quest Diagnostics (NYSE:DGX) from SmarTrend ... FOXBusiness SmarTrend, our proprietary pattern recognition system, called an Uptrend for Quest Diagnostics (NYSE:DGX) on October 09, 2009 at $54.49. ... AAPL and TXN Trading Higher After Hours Following Earnings Briefing.com ... will levy financial transactions tax on capital inflows; says tax applies to capital inflows heading to fixed-income and stock investments -- Reuters). ... and more » LabCorp Shares Can Pass the Test Barron's With sales of $4.5 billion in 2008, it's smaller than archrival Quest Diagnostics (DGX), and depends on cholesterol screenings and other routine lab tests ... 11/14/2009 News from StockRing Blog about QUEST DIAGNOSTC (NYSE:DGX) Stock on Saturday, November 14, 2009 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... dgx, hold - quest diagnostics incorporated (nyse : dgx), dec 5, 47.30, +1.62, +3.55%, 1340943. 137. dhi, buy - dr horton, inc. (nyse : dhi), dec 5, 8.17, +0.35, +4.48%, 8307732. 138. dhr, hold - danaher corporation (nyse : dhr), dec 5 ... 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... dgx, hold - quest diagnostics incorporated (nyse : dgx), dec 5, 47.30, +1.62, +3.55%, 1340943. 137. dhi, buy - dr horton, inc. (nyse : dhi), dec 5, 8.17, +0.35, +4.48%, 8307732. 138. dhr, hold - danaher corporation (nyse : dhr), dec 5 ... 12/25/2008 stockring advise: sell 35% or 176, hold 39% or 195, buy ... dgx, buy - quest diagnostics incorporated (nyse : dgx), dec 24, 49.25, -0.04, -0.08%, 502576. 137. dhi, hold - dr horton, inc. (nyse : dhi), dec 24, 6.75, -0.09, -1.32%, 1208798. 138. dhr, hold - danaher corporation (nyse : dhr), dec 24 ... 11/22/2008 stockring buy-sell-hold ratings for s&p 500 stocks dgx, hold - quest diagnostics incorporated (nyse : dgx), nov 20, 40.96, -2.98, -6.78%, 1948412. 137. dhi, super sell - dr horton, inc. (nyse : dhi), nov 20, 4.52, -0.26, -5.44%, 7752294. 138. dhr, sell - danaher corporation (nyse : dhr) ... 12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ... dgx, hold - quest diagnostics incorporated (nyse : dgx), 4:08pm, 45.89, +1.58, +3.57%, 1266218. 137. dhi, hold - dr horton, inc. (nyse : dhi), 4:01pm, 7.28, +0.64, +9.64%, 11886512. 138. dhr, sell - danaher corporation (nyse : dhr) ... 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... dgx, hold - quest diagnostics incorporated (nyse : dgx), dec 5, 47.30, +1.62, +3.55%, 1340943. 137. dhi, buy - dr horton, inc. (nyse : dhi), dec 5, 8.17, +0.35, +4.48%, 8307732. 138. dhr, hold - danaher corporation (nyse : dhr), dec 5 ... 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... dgx, hold - quest diagnostics incorporated (nyse : dgx), dec 5, 47.30, +1.62, +3.55%, 1340943. 137. dhi, buy - dr horton, inc. (nyse : dhi), dec 5, 8.17, +0.35, +4.48%, 8307732. 138. dhr, hold - danaher corporation (nyse : dhr), dec 5 ... 12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ... dgx, hold - quest diagnostics incorporated (nyse : dgx), dec 3, 45.89, +1.58, +3.57%, 1266218. 137. dhi, hold - dr horton, inc. (nyse : dhi), dec 3, 7.28, +0.64, +9.64%, 11886512. 138. dhr, sell - danaher corporation (nyse : dhr), dec 3 ...    Abele John   Abrams George    Abrams Jonathan   Ackermann Josef   ACUSHNET   A.I.G.   AIG   Albright Madeleine   AMAZON.COM   AMERITRADE   Andelman David   Andreessen Marc   Angwin Julia   Anthony Jim   APAX PARTNERS   ARCH VENTURE PARTNERS   ARONSSON GROUP   Ashworth Paul   AT&T   AVON BOOKS   Bair Sheila   BANK OF AMERICA   BARCLAYS   Barton Rich   Bassett Angela   BEAR STEARNS   Begich Mark   Bell Bryon   Bennett Tony   Berke Barry   Bernanke Ben   BET   BETSEY JOHNSON   Biaggi Mario   Bierut Michael   Biondi Frank   Blankfein Lloyd   Blinder Alan   Bock Jeff   BOEING   Boncompagni Tatiana   Bond Adam   Bond Victoria   Born Brooksley   BOSTON SCIENTIFIC   BP   Brazinski Daniel   Breslin Jimmy   Brody Kenneth   Brown Greg   Burkle Ron   Burow Kristina   Burrough Bryan   Bush George W.   Callan Erin   CALLAWAY GOLF   CARLYLE GROUP    CASCADE INVESTMENT   Cassano Joseph   Dauman Philippe   De Niro Robert   Dickerson Paul   Dillon Harrison   DISNEY   Dodd Christopher   Donaldson William   Douglas Michael   Draghi Mario   DREAMWORKS SKG   DUTTON   Dykstra Lenny   Eisner Michael   ELECTRONIC ARTS   Emanuel Rahm   ENRON   ESL INVESTMENTS   Evans Robert   Falcone Philip   FANNIE MAE   FEDERATED DEPARTMENT   STORES   FINANCO   Flavin Jennifer   Fleckenstein Bill   Foreman George   Frank Barney   Frears Stephen   FREDDIE MAC   Freston Tom   Friedman Stephen   Fuld Dick   Furman Roy   Garavani Valentino   Gates Bill   Geffen David   Geithner Tim   GENERAL MOTORS   Gensler Gary   Gerdeman Fred   Gibson Charles   GLASSDOOR   GLG PARTNERS   GOLDMAN SACHS   Greenspan Alan   Greenspan Glenn   Grey Brad   Griffin Kathy   Griffin Ken   Grove Andy   HALSTON   HARBINGER CAPITAL   PARTNERS   Harrison Gilbert   Harrison Mya   HCR MANORCARE   HEWLETT-PACKARD   HILCO CONSUMER   CAPITAL   Hohman Robert   JEFFRIES & CO.   Jobs Steve   Johnson Magic   Johnson Robert   Jolie Angelina   Jordan Michael   JP MORGAN CHASE   Kaczynski Ted   Karan Donna   Kargman Jill   Karmazin Mel   Kashkari Neel   King Larry   Knowles Beyonce   KohlbergJerry   KopelmanArie   KopelsonAnne   KopelsonArnold   Korff Ira   Korff Kimberlee   Kurzman David   Lagrange Pierre   Lampert Eddie   Lansing Sherry   LEHMAN BROTHERS   LENDINGTREE   Levitt Arthur   Levy Leon   Liddy Ed   LINKEDIN   Little Edward   Loeb Allan   Lois George   LONG-TERM CAPITAL   MANAGEMENT   Lonski John   Lundgren Terry   MACYS   Madoff Bernie   Marcus Bernie   Marriott Bill   Maskin Eric   Mason Richard   MATTHEW WILLIAMSON   MAY DEPARTMENT   STORES   McCombs Red   McKinnon Mark   McLucas William   Meltzer Allan   MERRILL LYNCH   MGM   MICROSOFT   MIDWAY GAMES   Misner Jeff   Mitchell Andrea   Moglia Joe   Molinaro Sam   MOODYS INVESTORS   SERVICE   Moonves Leslie   Morgan Peter   MORGAN STANLEY   Moses Herb   MOTOROLA   Mozilo Angelo   Murdoch Rupert   Murphy Eddie   MYSPACE   Nader Ralph   Nardelli Bob   NATIONAL AMUSEMENTS   NEWS CORP.   Nicholas Pete   Nicklaus Tack   NICKLAUS DESIGN   NIKE   Norquist Grover   NRDC EQUITY PARTNERS   Obama Barack   ODYSSEY PARTNERS   Oman Brady   OPPENHEIMER & CO.   OReilly Bill   OReilly Tim   OVERTURE FILMS   Paese Michael   Palin Sarah   PALM   Pandit Vikram   PARAMOUNT PICTURES   Partnoy Frank   Pataki George   Paulson Henry   Paulson John   Preston Kelly   Purcell Philip   Pyle Jason   RBS GREENWICH CAPITAL   Reardon Roy   Redstone Brent   Redstone Eddie   Redstone Michael   Redstone Paula   Redstone Phyllis   Redstone Shari   Redstone Sumner   RELIANCE   RENAISSANCE TECHNOLOGIES   ROYAL DUTCH SHELL   Rubin Robert   SAC CAPITAL ADVISORS   SALTON   SAPPHIRE ENERGY   Schiff Stephen   Schrager Ian   Schumer Chuck   Schwartz Alan   Scott Lee   Shields Brooke   SHUTTERFLY   SIEMENS   Silverman Ben   Simons James   SIX APART   SOCIALIZR   SOLAZYME   Sorkin Aaron   Sorkin Andrew Ross   Soros George   Spielberg Steven   Spurlock Morgan   Stallone Sylvester   Stanley Stephen   Staubach Roger   Steel Robert   Steinberg Mark   Stern Andy   Stiglitz Joseph   ST. MARTINS PRESS   Stone Oliver   Sullivan Mark T.   Summers Lawrence   SUTTER HILL VENTURES   TACONIC CAPITAL PARTNERS   DESIGN TOMMY HILFIGER   Travolta John   Trump Ivanka   TSM CAPITAL   CENTURY FOX   AFRIKA   TYCO   UBS   UNITED ARTISTS   UNIVERSAL   VALENTINO FASHION   GROUP   VANTAGE   V AUSTRALIA   VENROCK ASSOCIATES   VIA COM   Volcker Paul   VONAGE   WACHOVIA   Wagner Paula   Wales Jimmy   Wallison Peter   WAL-MART   WarinJoseph   WARNER BROTHERS   WASHINGTON MUTUAL   Waters Maxine   Waxman Henry   Weinstein Bob   Weinstein Harvey   WEINSTEIN CO.   Weiser Stanley   Welch Jack   Welling Beau   Whitacre Ed   White Kevin   Whitehead John   Williams Brian   Wilson Victoria   WMS INDUSTRIES   Wolfson Jonathan    Copyright © 2009 StockRing.com. All rights reserved. Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.

Buy from S&P 500:
Akamai - AKAM
Amazon.com - AMZN
Big Lots - BIG


Sell from S&P 500:
Alcoa - AA
Autodesk - ADSK
Aflac - AFL


Buy from S&P 400 MidCap:
Carmax - KMX
99c Stores - NDN
Netflix - NFLX


Sell from S&P 400 MidCap:
Timken - TKR
Trinity - TRN
Aflac - AFL


Buy from S&P 600 SmallCap:
Coinstar - CSTR
Holly - HOC
Maximus - MMS


Sell from S&P 600 SmallCap:
Barnes - B
Cascade - CAE
Brightpoint - CELL


Buy from Nasdaq 100:
Baidu.com - BIDU
Verisign - VRSN
Yahoo - YHOO


Sell from Nasdaq 100:
Adobe - ADBE
Amgen - AMGN
Costco - COST


Buy from Nasdaq Telecom:
Adtran - ADTN
CalAmp - CAMP
KongZhong - KONG


Sell from Nasdaq Telecom:
iBasis - IBAS
Interphase - INPH
RCN Corp - RCNI


Buy from Nasdaq Biotech:
Eurand - EURX
Illumina - ILMN
Trimeris - TRMS


Sell from Nasdaq Biotech:
Antigenics - AGEN
Celera - CRA
Incyte - INCY


Buy from Nasdaq Computer:
eLoyalty - ELOY
LogicVision - LGVN
Macrovision - MVSN


Sell from Nasdaq Computer:
Amtech - ASYS
Bsquare - BSQR
Corel - CREL


Buy from Nasdaq Finance:
Elbit - EMITF
Chardan - CACA
Tree.com - TREE


Sell from Nasdaq Finance:
BancFirst - BANF
FirstMerit - FMER
Advanta - ADVNA